Group
|
Author
|
Year
|
Country
|
Tumour type
|
No. Patients
|
No. Nodes
|
Reference method
|
CK19 IHC
|
Analysis of discordant cases
|
---|
1)
|
Tsujimoto et al. [15]
|
2007
|
Japan
|
Breast
|
101
|
325
|
H&E and IHC
|
yes
|
yes
|
Feldman et al. [28]
|
2011
|
USA
|
Breast
|
496
|
1044
|
H&E and IHC
|
yes
|
yes
|
Le Frère-Belda et al. [29]
|
2012
|
France
|
Breast
|
233
|
503
|
H&E and IHC
|
yes
|
yes
|
Vegué et al. [30]
|
2012
|
Spain
|
Breast
|
57
|
567
|
H&E
|
yes
|
no
|
Wang et al. [31]
|
2012
|
China
|
Breast
|
552
|
1188
|
H&E
|
no
|
yes
|
Pathmanathan et al. [32]
|
2014
|
Australia
|
Breast
|
98
|
170
|
H&E and IHC
|
no
|
no
|
Banerjee et al. [33]
|
2014
|
UK
|
Breast
|
170
|
268
|
H&E
|
no
|
no
|
Li et al. [34]
|
2015
|
China
|
Breast
|
115
|
311
|
H&E
|
no
|
yes
|
2)
|
Croner et al. [35]
|
2010
|
Germany
|
Colorectal
|
184
|
184
|
H&E and IHC
|
yes
|
yes
|
Yamamoto et al. [36]
|
2011
|
Japan
|
Colorectal
|
85
|
385
|
H&E
|
no
|
yes
|
Guller et al. [37]
|
2012
|
Switzerland
|
Colorectal
|
22
|
313
|
H&E and IHC
|
yes
|
yes
|
Yamamoto et al. [38]
|
2016
|
Japan
|
Colorectal
|
204
|
1925
|
H&E
|
no
|
no
|
Yaguchi et al. [39]
|
2011
|
Japan
|
Gastric
|
32
|
162
|
H&E
|
no
|
yes
|
Kumagai et al. [40]
|
2014
|
Japan
|
Gastric
|
61
|
394
|
H&E
|
no
|
yes
|
Shimada et al. [41]
|
2019
|
Japan
|
Gastric
|
43
|
439
|
H&E
|
no
|
yes
|
3)
|
Okamoto et al. [42](29)
|
2013
|
Japan
|
Cervical
|
32
|
130
|
H&E
|
no
|
yes
|
Nagai et al. [43]
|
2015
|
Japan
|
Endometrial
|
35
|
137
|
H&E
|
no
|
yes
|
Fanfani et al. [44]
|
2018
|
Italy
|
Endometrial
|
40
|
110
|
H&E and IHC
|
yes
|
no
|
Kost’un et al. [45](30)
|
2019
|
Czech Republic
|
Endometrial
|
58
|
135
|
H&E and IHC
|
yes
|
no
|
4)
|
Inoue et al. [46]
|
2012
|
Japan
|
Lung
|
49
|
165
|
H&E and IHC
|
no
|
no
|
Nakagawa et al. [47]
|
2016
|
Japan
|
Lung
|
111
|
410
|
H&E
|
no
|
yes
|
Escalante-Pérez et al. [48]
|
2019
|
Spain
|
Lung
|
160
|
705
|
H&E and IHC
|
yes
|
no
|
5)
|
Goda et al. [49]
|
2012
|
Japan
|
HNSCC
|
65
|
312
|
H&E
|
no
|
yes
|
Sofía del Carmen et al. [50]
|
2016
|
Spain
|
Thyroid
|
37
|
267
|
H&E and IHC
|
yes
|
yes
|
6)
|
Engels et al. [24]
|
2021
|
Germany
|
Prostate
|
64
|
534
|
H&E and IHC
|
yes
|
yes
|
- CK19 Cytokeratin 19, FN False negative, FP False positive, HNSCC Head and neck squamous cell carcinoma, H&E Hematoxylin and eosin, IHC Immunohistochemistry, No Number of, TN True negative, TP True positive